BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11469868)

  • 1. Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions.
    Sissi C; Perdonà E; Domenici E; Feriani A; Howells AJ; Maxwell A; Palumbo M
    J Mol Biol; 2001 Aug; 311(1):195-203. PubMed ID: 11469868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
    J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
    Hammonds TR; Foster SR; Maxwell A
    J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of nalidixic acid and ciprofloxacin with wild type and mutated quinolone-resistance-determining region of DNA gyrase A.
    Vashist J; Vishvanath ; Kapoor R; Kapil A; Yennamalli R; Subbarao N; Rajeswari MR
    Indian J Biochem Biophys; 2009 Apr; 46(2):147-53. PubMed ID: 19517991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression in Escherichia coli of Y5-mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1997; 38(3):188-201. PubMed ID: 9435021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of DNA gyrase with the bacterial toxin CcdB: evidence for the existence of two gyrase-CcdB complexes.
    Kampranis SC; Howells AJ; Maxwell A
    J Mol Biol; 1999 Oct; 293(3):733-44. PubMed ID: 10543963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of metal ions on the structure and stability of the DNA gyrase B protein.
    Sissi C; Marangon E; Chemello A; Noble CG; Maxwell A; Palumbo M
    J Mol Biol; 2005 Nov; 353(5):1152-60. PubMed ID: 16223508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complex of DNA gyrase and quinolone drugs on DNA forms a barrier to the T7 DNA polymerase replication complex.
    Wentzell LM; Maxwell A
    J Mol Biol; 2000 Dec; 304(5):779-91. PubMed ID: 11124026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex.
    Critchlow SE; Maxwell A
    Biochemistry; 1996 Jun; 35(23):7387-93. PubMed ID: 8652515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two short peptides including segments of subunit A of Escherichia coli DNA gyrase as potential probes to evaluate the antibacterial activity of quinolones.
    Marchetto R; Nicolás E; Castillo N; Bacardit J; Navia M; Vila J; Giralt E
    J Pept Sci; 2001 Jan; 7(1):27-40. PubMed ID: 11245203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
    Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
    J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of distinct ciprofloxacin susceptibility in Acinetobacter spp. by detection of the gyrA gene mutation using real-time PCR.
    Sheng WH; Lin YC; Wang JT; Chen YC; Chang SC; Hsia KC; Wu RJ; Li SY
    Mol Cell Probes; 2009; 23(3-4):154-6. PubMed ID: 19281841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of DNA gyrase-mediated illegitimate recombination: characterization of Escherichia coli gyrA mutations that confer hyper-recombination phenotype.
    Ashizawa Y; Yokochi T; Ogata Y; Shobuike Y; Kato J; Ikeda H
    J Mol Biol; 1999 Jun; 289(3):447-58. PubMed ID: 10356321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study.
    Holdgate GA; Tunnicliffe A; Ward WH; Weston SA; Rosenbrock G; Barth PT; Taylor IW; Pauptit RA; Timms D
    Biochemistry; 1997 Aug; 36(32):9663-73. PubMed ID: 9245398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of a method of single-stranded DNA fragment conformation polymorphism (SSCP) for detecting resistance of Mycoplasm hominis to fluoroquinolones].
    Gushchin AE; Taganov KD; Topol' IuIu; Govorun VM
    Mol Gen Mikrobiol Virusol; 1998; (4):37-40. PubMed ID: 9987752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal and urea-induced unfolding of the marginally stable lac repressor DNA-binding domain: a model system for analysis of solute effects on protein processes.
    Felitsky DJ; Record MT
    Biochemistry; 2003 Feb; 42(7):2202-17. PubMed ID: 12590610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.